Koch, C.; Göller, M.; Schott, E.; Waidmann, O.; op den Winkel, M.; Paprottka, P.; Zangos, S.; Vogl, T.; Bechstein, W.O.; Zeuzem, S.;
et al. Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers. Cancers 2021, 13, 2121.
https://doi.org/10.3390/cancers13092121
AMA Style
Koch C, Göller M, Schott E, Waidmann O, op den Winkel M, Paprottka P, Zangos S, Vogl T, Bechstein WO, Zeuzem S,
et al. Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers. Cancers. 2021; 13(9):2121.
https://doi.org/10.3390/cancers13092121
Chicago/Turabian Style
Koch, Christine, Markus Göller, Eckart Schott, Oliver Waidmann, Mark op den Winkel, Philipp Paprottka, Stephan Zangos, Thomas Vogl, Wolf Otto Bechstein, Stefan Zeuzem,
and et al. 2021. "Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers" Cancers 13, no. 9: 2121.
https://doi.org/10.3390/cancers13092121
APA Style
Koch, C., Göller, M., Schott, E., Waidmann, O., op den Winkel, M., Paprottka, P., Zangos, S., Vogl, T., Bechstein, W. O., Zeuzem, S., Kolligs, F. T., & Trojan, J.
(2021). Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers. Cancers, 13(9), 2121.
https://doi.org/10.3390/cancers13092121
